[go: up one dir, main page]

MX2019006464A - Nutrientes esenciales y metodos relacionados. - Google Patents

Nutrientes esenciales y metodos relacionados.

Info

Publication number
MX2019006464A
MX2019006464A MX2019006464A MX2019006464A MX2019006464A MX 2019006464 A MX2019006464 A MX 2019006464A MX 2019006464 A MX2019006464 A MX 2019006464A MX 2019006464 A MX2019006464 A MX 2019006464A MX 2019006464 A MX2019006464 A MX 2019006464A
Authority
MX
Mexico
Prior art keywords
choline
combinations
composition
fatty acids
pharmaceutical compositions
Prior art date
Application number
MX2019006464A
Other languages
English (en)
Inventor
David Bortz Jonathan
Original Assignee
Balchem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Balchem Corp filed Critical Balchem Corp
Publication of MX2019006464A publication Critical patent/MX2019006464A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente descripción se refiere a las composiciones farmacéuticas para el consumo de mamíferos que contienen ácidos grasos esenciales, proteína, vitaminas, colina o combinaciones de estos, constituidas de este modo para optimizar la absorción y/o el transporte y/o la eficiencia de los coingredientes de la composición. Las composiciones farmacéuticas son útiles como suplementos para proporcionar nutrientes a pacientes con carencias nutricionales. La composición puede contener ácidos grasos esenciales, tales como EPA, DHA y/o ALA, proteína de unión a la cobalamina, tal como el factor intrínseco, vitamina B12 o una forma sintética de esta, colina, tal como bitartrato de colina o combinaciones de estos.
MX2019006464A 2016-12-09 2017-12-07 Nutrientes esenciales y metodos relacionados. MX2019006464A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662432468P 2016-12-09 2016-12-09
PCT/US2017/065118 WO2018106921A1 (en) 2016-12-09 2017-12-07 Essential nutrients and related methods

Publications (1)

Publication Number Publication Date
MX2019006464A true MX2019006464A (es) 2019-08-21

Family

ID=62488201

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019006464A MX2019006464A (es) 2016-12-09 2017-12-07 Nutrientes esenciales y metodos relacionados.

Country Status (7)

Country Link
US (1) US20180161299A1 (es)
EP (1) EP3551292A4 (es)
AU (1) AU2017370929A1 (es)
BR (1) BR112019011310A2 (es)
CA (1) CA3043920A1 (es)
MX (1) MX2019006464A (es)
WO (1) WO2018106921A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180121962A (ko) * 2016-03-22 2018-11-09 발켐 코포레이션 콜린을 포함하는 조성물
SG11202005905TA (en) * 2017-12-21 2020-07-29 Aker Biomarine Antarctic As Lysophosphatidylcholine compositions
GB202112170D0 (en) * 2021-08-25 2021-10-06 Mitocholine Ltd Nutritional compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000010A2 (en) * 2001-06-20 2003-01-03 Mayo Foundation For Medical Education And Research Adenosyl-cobalamin fortified compositions
US7718198B2 (en) * 2001-06-20 2010-05-18 Metaproteomics, Llc Treatment modalities for autoimmune diseases
US7429569B2 (en) * 2004-01-29 2008-09-30 Fast Balance, Inc. Compositions and methods for the regulation of homocysteine levels within the body
US8075910B2 (en) * 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
US20090035385A1 (en) * 2004-12-22 2009-02-05 Drugtech Corporation Compositions including iron
US8280025B2 (en) * 2007-06-29 2012-10-02 Microsoft Corporation Automated unique call announcement
CA2695366C (en) * 2007-08-03 2016-10-04 Shaklee Corporation Nutritional supplement system
CA2905143A1 (en) * 2013-03-15 2014-09-18 Exeltis Usa, Inc. Gummy compositions for nutritional supplementation
US11795754B2 (en) * 2013-07-14 2023-10-24 Ecolink Intelligent Technology, Inc. Method and apparatus for controlling a movable barrier system
US20150132273A1 (en) * 2013-11-09 2015-05-14 Rhett Sean Daniels Nutritional Compositions and Methods for Treating Cognitive Impairment
WO2015115885A1 (en) * 2014-01-31 2015-08-06 N.V. Nutricia Method for reducing white matter lesions, white matter hyperintensities (wmh), leukoaraiosis or periventricular white matter disease in elderly
GB201405033D0 (en) * 2014-03-20 2014-05-07 Isis Innovation Combination therapy

Also Published As

Publication number Publication date
BR112019011310A2 (pt) 2019-10-15
WO2018106921A1 (en) 2018-06-14
US20180161299A1 (en) 2018-06-14
EP3551292A1 (en) 2019-10-16
AU2017370929A1 (en) 2019-06-06
CA3043920A1 (en) 2018-06-14
EP3551292A4 (en) 2020-08-05

Similar Documents

Publication Publication Date Title
EA201070419A1 (ru) Состав для регулирования метаболизма липидов
CL2022002775A1 (es) Composiciones que comprenden algas y métodos de uso de las mismas para aumentar la producción de productos animales
WO2013049519A3 (en) Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols
AR103260A1 (es) Modulación inmunitaria
EA201991289A1 (ru) Быстродействующие лекарственные соединения и пищевые добавки растительного происхождения
CL2019002640A1 (es) Moléculas propioticas para reducir virulencia de patógenos.
AR076676A1 (es) Lactobacillus johnsonii la1 ncc533 (cncm i-1225) y trastornos inmunes
PE20142333A1 (es) Suplementacion con hierro de granos de arroz
PH12018500035A1 (en) Nutritional compositions and methods for promoting cognitive development
PH12013501433A1 (en) High protein nutritional compositions and methods of making and using same
AR098653A1 (es) Composición útil para promover la fertilidad femenina, composición de combinación
PH12018500090A1 (en) Nutritional compositions and methods for promoting cognitive development
MX344271B (es) Productos nutricionales que incluyen un sistema de grasa novedoso que incluye monogliceridos.
PH12018500036A1 (en) Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
MX2018009819A (es) Soporte nutricional para animales mediante la administracion de un suplemento derivado de algas.
PH12019501293A1 (en) Nutritional compositions containing butyrate and uses thereof
PH12015502057A1 (en) Method of enhancing bioavailability of dha and other lipid-soluble nutrients
MX2020009677A (es) Composiciones preparadas de aves de corral y metodos de su uso.
MX2019006464A (es) Nutrientes esenciales y metodos relacionados.
MX2012010487A (es) Composicion de nutrimientos y sustancias bioactivas que favorecen el crecimiento y que disminuyen la intolerancia y los efectos adversos en infantes prematuros.
MX373270B (es) Composiciones y metodos para mejorar el rendimiento del ejercicio.
MX2015013165A (es) Composiciones nutricionales para infantes prematuros que contienen acido beta-hidroxi-beta-metilbutirico para promover el crecimiento y la acrecion de masa corporal magra en infantes prematuros.
JP2010275318A5 (es)
CL2019001708A1 (es) Métodos para producir biomasa rica en dha, ácido palmítico y proteínas con un microorganismo eucariota.
PH12017500916A1 (en) Method of increasing levels of omega-3 fatty acids in beef products by administration of a grass and algae diet